Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale

NCT06953622 · clinicaltrials.gov ↗

RECRUITING

Status

330

Enrollment

OTHER

Sponsor class

Conditions

Migraine
Patent Foramen Ovale

Interventions

DRUG: Conservative treatment
DRUG: Antipaletet drug
PROCEDURE: Patent Foramen Ovale Closure

Sponsor

Peking University Third Hospital